Enanta Pharmaceuticals sets up $75M at-the-market stock offering

Enanta Pharmaceuticals (NASDAQ: ENTA) has entered into an open market sale agreement with Jefferies LLC, dated July 2, 2026, to sell up to $75,000,000 worth of common stock through an at-the-market offering.

Under the terms of the agreement, Enanta may offer and sell shares of its common stock, with a par value of $0.01 per share, from time to time through Jefferies acting as sales agent. Jefferies will receive a commission of up to 3.0% of gross proceeds from any shares sold under the agreement.

Jefferies is not required to sell any specific number or dollar amount of shares and will act using commercially reasonable efforts consistent with its normal trading and sales practices. No escrow or trust arrangement has been established for the funds.

Enanta's common stock is listed on the Nasdaq Global Select Market under the ticker symbol "ENTA." The last reported sale price of the stock was $14.77 per share as of July 1, 2026.

The information above is based on an SEC filing submitted by Enanta Pharmaceuticals.

You May Also Be Interested In

• Alphabet Sees FY26 Capex $195B To $205B, Saw $180B To $190B
• Progress Software to acquire Domo's assets for $400 million in cash
• Solowin Holdings unit signs payment services deal with Attrus in Latin America